Literature DB >> 18206796

One-year follow-up in a child with McArdle disease: exercise is medicine.

Margarita Pérez1, Carl Foster, Marta González-Freire, Joaquín Arenas, Alejandro Lucia.   

Abstract

A 9-year-old boy with McArdle disease, who demonstrated remarkable recovery of objectively measured exercise tolerance after 1 year of follow-up, during which he pursued age-appropriate physical activities. The patient presented 1 year previously with severe myalgia, muscle weakness, proteinuria, hematuria, hyperthermia, and elevated creatine kinase levels after noncompetitive swimming. At that time, he reported a 3-year history of general myalgia and poor exercise tolerance. He was diagnosed with McArdle disease by both biochemical and genetic methods. Subsequently he performed a maximal exercise test and was prescribed a return to age-appropriate physical activity (protected by a pre-exercise dietary consumption of approximately 20 g carbohydrate). At 1-year follow up, he reported no subsequent acute clinical episodes, no general problems with exercise either at school or in ordinary activities, a virtual normalization of serum creatine kinase levels, and a 14% increase in body mass-adjusted peak oxygen uptake (from 18.8 to 21.8 mL O2/kg/min). The results suggest that, with protection by increasing pre-exercise blood glucose with carbohydrate ingestion, a substantially normal lifestyle may be possible in some children with McArdle disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206796     DOI: 10.1016/j.pediatrneurol.2007.10.005

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

Review 1.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

2.  Clinical and molecular characterization of McArdle's disease in Brazilian patients.

Authors:  Juliana Gurgel-Giannetti; Gisela Nogales-Gadea; Hélio van der Linden; Túlio Marcus Ribeiro Bellard; Geraldo Brasileiro Filho; Alexandre Varella Giannetti; Eralda Luiza de Castro Concentino; Mariz Vainzof
Journal:  Neuromolecular Med       Date:  2013-05-08       Impact factor: 3.843

3.  The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Astrid Brull; Noemi de Luna; Alejandro Lucia; Tomàs Pinós
Journal:  J Inherit Metab Dis       Date:  2014-07-23       Impact factor: 4.982

4.  Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.

Authors:  A Manta; S Spendiff; H Lochmüller; R Thompson
Journal:  J Neuromuscul Dis       Date:  2021

5.  Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits.

Authors:  Alfredo Santalla; Diego Munguía-Izquierdo; Lidia Brea-Alejo; Itziar Pagola-Aldazábal; Jorge Díez-Bermejo; Steven J Fleck; Ignacio Ara; Alejandro Lucia
Journal:  Front Aging Neurosci       Date:  2014-12-11       Impact factor: 5.750

6.  Higher oxidative stress in skeletal muscle of McArdle disease patients.

Authors:  Jan J Kaczor; Holly A Robertshaw; Mark A Tarnopolsky
Journal:  Mol Genet Metab Rep       Date:  2017-06-09

7.  Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Alberto Blázquez Encinar; Irene Vieitez; Adrian González-Quintana; Pablo Serrano-Lorenzo; Inés García Consuegra; Sara Asensio; Alfonsina Ballester-Lopez; Guillem Pintos-Morell; Jaume Coll-Cantí; Helios Pareja-Galeano; Jorge Díez-Bermejo; Margarita Pérez; Antoni L Andreu; Tomàs Pinós; Joaquín Arenas; Miguel A Martín; Alejandro Lucia
Journal:  BMC Genomics       Date:  2017-11-14       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.